Best discriminatory combinations of markers for papillary carcinoma from follicular adenoma, and non-neoplastic lesions were CD56 with Galectin 3, and CK19 with Galectin 3, respectively. This evidence concerns the gene NCAM1 and follicular thyroid adenoma.